Adage Capital Partners Gp, L.L.C. Celcuity Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Celcuity Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 658,000 shares of CELC stock, worth $10.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
658,000Holding current value
$10.4 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CELC
# of Institutions
82Shares Held
22.9MCall Options Held
24.9KPut Options Held
4K-
Perceptive Advisors LLC New York, NY2.36MShares$37.3 Million1.07% of portfolio
-
Morgan Stanley New York, NY2.35MShares$37.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.73MShares$27.4 Million3.06% of portfolio
-
Commodore Capital LP New York, NY1.56MShares$24.6 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY1.55MShares$24.5 Million0.42% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $236M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...